Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-1284
Injection Pen Market is estimated to value over CAGR of over 5.7% during the forecast period 2022 to 2028. Injection pens are prefilled syringes that are used to administer drugs into the body. They are commonly used to dispense insulin to diabetic patients as well as for fertility and therapy treatments. They have a number of advantages, namely because they are different from the regular syringe and vial usage. The simple handling, application and maintenance are factors which shall augment the global injection pen market growth further. The demand for injection pens is anticipated to gain significant traction in the market due to the growing presence of chronic diseases on a global scale, a rise in approvals and sanctions by regulatory bodies, as well as considerable reimbursements. However, the tendency to opt for alternative drug delivery methods and the relatively low reimbursement in developing nations, are factors which could pose hindrances to the market. The disposable injection pens market is expected to account for the highest CAGR during the forecast time frame. Factors such as user-friendliness, portability and a reduced possibility of infection, is likely to spur the market growth. Going by the basis of therapy, the market for injection pens is divided into, growth hormone therapy, diabetes, fertility, osteoporosis, and other therapies. The high growth of the injection pen segment can be linked to the large population pool and profound reimbursements for diabetes related treatments in developed nations. The diabetes segment is then categorized into GLP-1and insulin. Major players in the global injection pen market are: Ypsomed (Switzerland), Sanofi (France), Owen Mumford (UK), Haselmeier (Switzerland), Merck (US), Becton Dickinson and Company (US), Eli Lilly (US), F.Hoffman-La Roche (Switzerland), AstraZeneca (UK), Pfizer (US), Novartis (Switzerland). Injection Pen Market Segmentation: By Type Disposable Injection Pen Reusable Injection Pen By Application • Diabetes o Insulin o Non-insulin • Anaphylaxis • Osteoporosis • Growth hormone deficiency • Arthritis • Fertility • Others By End User Home Care Hospitals & Clinics By Region Europe North America Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global injection pen market by dosage type, by application, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Injection pens are prefilled syringes that are used to administer drugs into the body. They are commonly used to dispense insulin to diabetic patients as well as for fertility and therapy treatments. They have a number of advantages, namely because they are different from the regular syringe and vial usage. The simple handling, application and maintenance are factors which shall augment the global injection pen market growth further.
The demand for injection pens is anticipated to gain significant traction in the market due to the growing presence of chronic diseases on a global scale, a rise in approvals and sanctions by regulatory bodies, as well as considerable reimbursements. However, the tendency to opt for alternative drug delivery methods and the relatively low reimbursement in developing nations, are factors which could pose hindrances to the market.
The disposable injection pens market is expected to account for the highest CAGR during the forecast time frame. Factors such as user-friendliness, portability and a reduced possibility of infection, is likely to spur the market growth. Going by the basis of therapy, the market for injection pens is divided into, growth hormone therapy, diabetes, fertility, osteoporosis, and other therapies. The high growth of the injection pen segment can be linked to the large population pool and profound reimbursements for diabetes related treatments in developed nations. The diabetes segment is then categorized into GLP-1and insulin.
Major players in the global injection pen market are:
Ypsomed (Switzerland), Sanofi (France), Owen Mumford (UK), Haselmeier (Switzerland), Merck (US), Becton Dickinson and Company (US), Eli Lilly (US), F.Hoffman-La Roche (Switzerland), AstraZeneca (UK), Pfizer (US), Novartis (Switzerland). Injection Pen Market Segmentation:
By Type
By Application
• Diabetes o Insulin o Non-insulin • Anaphylaxis • Osteoporosis • Growth hormone deficiency • Arthritis • Fertility • Others
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Injection Pen Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Injection Pen Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Injection Pen Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Injection Pen Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Injection Pen Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1 Disposable Injection Pen 7.2 Reusable Injection Pen 8. Global Injection Pen Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Diabetes 8.1.1. Insulin 8.1.2. Non-insulin 8.2. Anaphylaxis 8.3. Osteoporosis 8.4. Growth hormone deficiency 8.5. Arthritis 8.6. Fertility 8.7. Others 9. Global Injection Pen Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Home Care 9.2. Hospitals & Clinics 10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Ypsomed (Switzerland) 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Sanofi (France) 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Owen Mumford (UK) 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Haselmeier (Switzerland) 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Merck (US) 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Becton Dickinson and Company (US) 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Eli Lilly (US) 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. F.Hoffman-La Roche (Switzerland) 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. AstraZeneca (UK) 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Pfizer (US) 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11 Novartis (Switzerland) 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics